David Hung

Affiliations

  • President And Ceo at Nuvation Bio Inc. (NUVB), 2025-06-18
  • at Novocure Ltd (NVCR), 2025-06-06
  • Director at Arya Sciences Acquisition Corp. (ARYA), 2020-07-07
  • Director at Establishment Labs Holdings Inc. (ESTA), 2020-05-27
  • Principal Executive Officer at Axovant Sciences Ltd. (AXON), 2018-01-03
  • President And Ceo at Medivation Inc. (MDVN), 2016-09-30
  • Director at Opexa Therapeutics Inc. (OPXA), 2011-04-07
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NUVB $1.79 500,000 $893,500.00 59,281,054 2025-06-16 Filing
NUVB $1.63 300,000 $487,500.00 58,781,054 2025-04-07 Filing
NUVB $1.66 200,000 $332,720.00 58,481,054 2025-04-04 Filing
AXON $18.54 539,375 $10,000,012.50 539,375 2017-04-17 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NVCR $17.30 999 $17,279.50 12,195 2025-06-03 Filing
MDVN $41.10 5,085 $208,993.50 1,549,189 2016-03-04 Filing
MDVN $31.18 6,350 $197,993.00 1,504,654 2016-02-04 Filing
MDVN $43.10 10,950 $471,965.81 1,511,004 2015-12-03 Filing
MDVN $121.49 32,191 $3,910,884.59 760,977 2015-03-02 Filing